君实生物-U大涨广州生物医药受关注

智选洞察12-02

12月02日，君实生物-U（688180）股价大幅上涨，截至10点30分，君实生物-U上涨5.00%，报32.74元/股，成交2.25亿元，换手率0.91%。消息解读据中新网，由广州市市场监管局(知识产权局)主办的广州市生物医药产业知识产权强链增效行动启动会在广州国际生物岛举行。从会上获悉，目前广州生物医药产业居全国第一梯队，构建了集技术研发、临床试验、转化中试、生产制造、上市应用、流通销售一体的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2488461256?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-02 10:30","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2488461256","market":"sh","top_or_hot":-1,"title":"君实生物-U大涨 广州生物医药受关注","media":"智选洞察","content":"<div>\n<p>12月02日，君实生物-U（688180）股价大幅上涨，截至10点30分，君实生物-U上涨5.00%，报32.74元/股，成交2.25亿元，换手率0.91%。消息解读据中新网，由广州市市场监管局(知识产权局)主办的广州市生物医药产业知识产权强链增效行动启动会在广州国际生物岛举行。从会上获悉，目前广州生物医药产业居全国第一梯队，构建了集技术研发、临床试验、转化中试、生产制造、上市应用、流通销售一体的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202103100abee6aa2&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>君实生物-U大涨 广州生物医药受关注</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n君实生物-U大涨 广州生物医药受关注\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-02 10:30 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202103100abee6aa2&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>12月02日，君实生物-U（688180）股价大幅上涨，截至10点30分，君实生物-U上涨5.00%，报32.74元/股，成交2.25亿元，换手率0.91%。消息解读据中新网，由广州市市场监管局(知识产权局)主办的广州市生物医药产业知识产权强链增效行动启动会在广州国际生物岛举行。从会上获悉，目前广州生物医药产业居全国第一梯队，构建了集技术研发、临床试验、转化中试、生产制造、上市应用、流通销售一体的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202103100abee6aa2&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202103100abee6aa2&s=b","article_id":"2488461256","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202103100abee6aa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2488461256","pubTimestamp":1733106644,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"12月02日，君实生物-U股价大幅上涨，截至10点30分，君实生物-U上涨5.00%，报32.74元/股，成交2.25亿元，换手率0.91%。资金动向截止发稿，君实生物-U获得主力净流出1425万元，其中超大单流出1346万元，大单流出78万元。主营业务及业绩君实生物-U公司主营业务为单克隆抗体药物和其他治疗型蛋白药物的研发与产业化，单克隆抗体药物研发的技术服务与技术转让等。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"161726":"生物医药","399441":"生物医药","688180":"君实生物","BK0239":"医药制造"},"translate_title":"Junshi Bio-U surges, Guangzhou biomedicine attracts attention","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161726":1,"399441":1,"688180":1},"content_text":"12月02日，君实生物-U（688180）股价大幅上涨，截至10点30分，君实生物-U上涨5.00%，报32.74元/股，成交2.25亿元，换手率0.91%。消息解读据中新网，由广州市市场监管局(知识产权局)主办的广州市生物医药产业知识产权强链增效行动启动会在广州国际生物岛举行。从会上获悉，目前广州生物医药产业居全国第一梯队，构建了集技术研发、临床试验、转化中试、生产制造、上市应用、流通销售一体的完整产业链，形成产值超万亿元的产业集群。此外，数据统计显示，近半年内7家券商给予买入建议。资金动向截止发稿，君实生物-U获得主力净流出1425万元，其中超大单流出1346万元，大单流出78万元。数据显示，该股今日净流入较近5日净流入均值减少1555万元。主营业务及业绩君实生物-U公司主营业务为单克隆抗体药物和其他治疗型蛋白药物的研发与产业化，单克隆抗体药物研发的技术服务与技术转让等。最新财报显示，今年三季报，君实生物-U实现营业收入12.71亿元，同比增长28.87%，净利润为-9.27亿元，同比增长34.12%，基本每股收益为-0.94元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2488461256"}

君实生物-U大涨 广州生物医药受关注

精彩评论

君实生物-U大涨广州生物医药受关注